Weekly Digest – February 2025 Weekly Digest – February 2025 12 Feb 2025: U.S. FDA approves Pfizer’s ADCETRIS combination regimen for the treatment of relapsed/refractory diffuse large B-cell lymphoma The FDA approved ADCETRIS (Brentuximab vedotin) for treating adult patients with […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id